Jeff Walsh is the founder of Nvelop Therapeutics. Nvelop Therapeutics has raised $75M in total funding. Latest round: Seed.
Jeff Walsh was the CEO of Nvelop Therapeutics, a company launched in 2024 and founded in 2022. He led the company alongside CSO Melissa Bonner and was formerly an executive at bluebird bio. Nvelop Therapeutics later merged into nChroma Bio in December 2024.
Full founder directory · Investor directory · Company funding database · Fundraising library